| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | XENCOR INC COM | 20,000 | 245,000 | 0.01% | ||
| 2 | MACROGENICS INC | 12,743 | 273,000 | 0.01% | ||
| 3 | KITE PHARMA INCORPORATED | 6,300 | 351,000 | 0.01% | ||
| 4 | ZAFGEN INC COM | 13,307 | 425,000 | 0.02% | ||
| 5 | CIDARA THERAPEUTICS INC | 50,000 | 636,000 | 0.02% | ||
| 6 | CYNAPSUS THERAPEUTICS INC | 49,322 | 799,000 | 0.03% | ||
| 7 | GALAPAGOS NV | 20,000 | 814,000 | 0.03% | ||
| 8 | TRILLIUM THERAPEUTICS INC | 65,000 | 847,000 | 0.03% | ||
| 9 | BELLICUM PHARMACEUTICALS INCORPORATED | 60,000 | 872,000 | 0.03% | ||
| 10 | VERASTEM INC | 500,000 | 895,000 | 0.03% | ||
| 11 | Abaxis Inc | 22,466 | 988,000 | 0.04% | ||
| 12 | BIODELIVERY SCIENCES INTL IN | 250,000 | 1,390,000 | 0.05% | ||
| 13 | AFFIMED N V COM | 228,083 | 1,407,000 | 0.05% | ||
| 14 | TETRAPHASE PHARMACEUTICALS INC COM | 192,322 | 1,435,000 | 0.05% | PRN | |
| 15 | GENMARK DIAGNOSTICS INC. | 215,149 | 1,693,000 | 0.06% | ||
| 16 | CHIMERIX INC | 47,800 | 1,826,000 | 0.07% | ||
| 17 | UNIQURE NV | 102,800 | 2,102,000 | 0.08% | Call | |
| 18 | UNIQURE NV | 102,800 | 2,102,000 | 0.08% | ||
| 19 | DBV TECHNOLOGIES S A | 65,600 | 2,335,000 | 0.08% | ||
| 20 | MERRIMACK PHARMACEUTI | 1,485,000 | 2,336,000 | 0.08% | PRN | |
| 21 | ACCELERATE DIAGNOSTICS INC | 144,625 | 2,340,000 | 0.08% | ||
| 22 | TETRALOGIC PHARMACEUTICALS C | 4,500,000 | 2,360,000 | 0.08% | PRN | |
| 23 | ALNYLAM PHARMACEUTICALS INC | 29,500 | 2,371,000 | 0.09% | Call | |
| 24 | Esperion Therapeutics Inc | 102,800 | 2,425,000 | 0.09% | Call | |
| 25 | Esperion Therapeutics Inc | 102,800 | 2,425,000 | 0.09% | ||
| 26 | MOMENTA PHARMACEUTICALS INC | 153,700 | 2,522,000 | 0.09% | ||
| 27 | GRIFOLS S A SP ADR REP B | 83,000 | 2,523,000 | 0.09% | ||
| 28 | MEDICAL PPTYS TRUST INC | 70,300 | 2,669,000 | 0.10% | Call | |
| 29 | CARE CAP PPTYS INC | 84,316 | 2,777,000 | 0.10% | ||
| 30 | FLEX PHARMA INC COM | 232,600 | 2,794,000 | 0.10% | ||
| 31 | AEGERION PHARMACEUTICALS INC | 206,000 | 2,802,000 | 0.10% | ||
| 32 | ALEXION PHARMACEUTIC | 18,200 | 2,846,000 | 0.10% | Call | |
| 33 | PERRIGO CO PLC | 18,900 | 2,972,000 | 0.11% | ||
| 34 | FORWARD PHARMA A/S | 132,447 | 3,120,000 | 0.11% | ||
| 35 | TROVAGENE INC | 550,000 | 3,130,000 | 0.11% | ||
| 36 | HORIZON PHARMA PLC | 162,900 | 3,229,000 | 0.12% | ||
| 37 | HORIZON PHARMA PLC | 162,900 | 3,229,000 | 0.12% | Call | |
| 38 | WRIGHT MEDICAL GROUP NV | 156,100 | 3,281,000 | 0.12% | ||
| 39 | EPIZYME INC COM | 256,700 | 3,301,000 | 0.12% | ||
| 40 | KARYOPHARM THERAPEUTICS INC COM | 316,900 | 3,337,000 | 0.12% | Call | |
| 41 | ADAPTIMMUNE THERAPEUTICS PLC | 281,934 | 3,375,000 | 0.12% | ||
| 42 | PUMA BIOTECHNOLOGY | 45,400 | 3,421,000 | 0.12% | Call | |
| 43 | SAGE THERAPEUTICS INC | 82,800 | 3,504,000 | 0.13% | Call | |
| 44 | CELLDEX THERAPEUTICS INC NEW | 338,400 | 3,567,000 | 0.13% | ||
| 45 | BIOMARIN PHARMACEUTICAL INC | 35,500 | 3,739,000 | 0.13% | Call | |
| 46 | DEPOMED INC | 200,000 | 3,770,000 | 0.14% | ||
| 47 | ACHILLION PHARMACEUTICALS IN | 547,300 | 3,782,000 | 0.14% | ||
| 48 | GW PHARMACEUTICALS PLC | 41,400 | 3,783,000 | 0.14% | Call | |
| 49 | LEXICON PHARMACEUTICALS INC | 353,900 | 3,801,000 | 0.14% | Call | |
| 50 | LEXICON PHARMACEUTICALS INC | 353,900 | 3,801,000 | 0.14% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001104659-15-078613, filed 2015.11.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
